Does the media prefer BSX or ALGN?

In the previous week, Boston Scientific had 4 more articles in the media than Align Technology. MarketBeat recorded 21 mentions for Boston Scientific and 17 mentions for Align Technology. Align Technology's average media sentiment score of 1.20 beat Boston Scientific's score of 1.10 indicating that Align Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 15 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 11 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to HQY or BSX?

In the previous week, Boston Scientific had 18 more articles in the media than HealthEquity. MarketBeat recorded 21 mentions for Boston Scientific and 3 mentions for HealthEquity. Boston Scientific's average media sentiment score of 1.10 beat HealthEquity's score of 0.78 indicating that Boston Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 15 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer BSX or MMSI?

In the previous week, Boston Scientific had 17 more articles in the media than Merit Medical Systems. MarketBeat recorded 21 mentions for Boston Scientific and 4 mentions for Merit Medical Systems. Boston Scientific's average media sentiment score of 1.10 beat Merit Medical Systems' score of 1.06 indicating that Boston Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 15 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor AMN or BSX?

In the previous week, AMN Healthcare Services had 2 more articles in the media than Boston Scientific. MarketBeat recorded 23 mentions for AMN Healthcare Services and 21 mentions for Boston Scientific. Boston Scientific's average media sentiment score of 1.10 beat AMN Healthcare Services' score of 0.59 indicating that Boston Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 6 Very Positive mention(s) 4 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 15 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to CAH or BSX?

In the previous week, Cardinal Health had 11 more articles in the media than Boston Scientific. MarketBeat recorded 32 mentions for Cardinal Health and 21 mentions for Boston Scientific. Boston Scientific's average media sentiment score of 1.10 beat Cardinal Health's score of 0.70 indicating that Boston Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cardinal Health 13 Very Positive mention(s) 3 Positive mention(s) 12 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 15 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Boston Scientific (BSX) Competitors

$44.33 +0.13 (+0.29%)

Closing price 03:59 PM Eastern

Extended Trading

$44.08 -0.25 (-0.56%)

As of 06:30 PM Eastern

Compare

BSX vs. ALGN, HQY, MMSI, AMN, and CAH

Should you buy Boston Scientific stock or one of its competitors? Boston Scientific's main competitors and comparable companies include Align Technology (ALGN), HealthEquity (HQY), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), and Cardinal Health (CAH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Boston Scientific compare to Align Technology?

Boston Scientific (NYSE:BSX) and Align Technology (NASDAQ:ALGN) are both large-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

Boston Scientific presently has a consensus target price of $61.43, indicating a potential upside of 38.92%. Align Technology has a consensus target price of $193.08, indicating a potential upside of 15.64%. Given Boston Scientific's stronger consensus rating and higher possible upside, equities research analysts clearly believe Boston Scientific is more favorable than Align Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	2 Sell rating(s)	8 Hold rating(s)	20 Buy rating(s)	1 Strong Buy rating(s)	2.65
Align Technology	1 Sell rating(s)	7 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.53

In the previous week, Boston Scientific had 4 more articles in the media than Align Technology. MarketBeat recorded 21 mentions for Boston Scientific and 17 mentions for Align Technology. Align Technology's average media sentiment score of 1.20 beat Boston Scientific's score of 1.10 indicating that Align Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	15 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Align Technology	11 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Boston Scientific has a net margin of 16.62% compared to Align Technology's net margin of 11.83%. Boston Scientific's return on equity of 18.61% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	16.62%	18.61%	10.58%
Align Technology	11.83%	15.96%	10.48%

Boston Scientific has higher revenue and earnings than Align Technology. Boston Scientific is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.07B	3.19	$2.90B	$2.36	18.74
Align Technology	$4.03B	2.92	$410.35M	$6.87	24.30

Boston Scientific has a beta of 0.6, meaning that its share price is 40% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.74, meaning that its share price is 74% more volatile than the broader market.

89.1% of Boston Scientific shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 0.3% of Boston Scientific shares are owned by company insiders. Comparatively, 0.8% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Boston Scientific beats Align Technology on 11 of the 16 factors compared between the two stocks.

How does Boston Scientific compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Boston Scientific (NYSE:BSX) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

HealthEquity has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.6, meaning that its share price is 40% less volatile than the broader market.

HealthEquity currently has a consensus price target of $113.53, indicating a potential upside of 10.17%. Boston Scientific has a consensus price target of $61.43, indicating a potential upside of 38.92%. Given Boston Scientific's higher possible upside, analysts clearly believe Boston Scientific is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.92
Boston Scientific	2 Sell rating(s)	8 Hold rating(s)	20 Buy rating(s)	1 Strong Buy rating(s)	2.65

Boston Scientific has higher revenue and earnings than HealthEquity. Boston Scientific is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	6.49	$215.20M	$2.77	37.20
Boston Scientific	$20.07B	3.19	$2.90B	$2.36	18.74

In the previous week, Boston Scientific had 18 more articles in the media than HealthEquity. MarketBeat recorded 21 mentions for Boston Scientific and 3 mentions for HealthEquity. Boston Scientific's average media sentiment score of 1.10 beat HealthEquity's score of 0.78 indicating that Boston Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Boston Scientific	15 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity has a net margin of 17.36% compared to Boston Scientific's net margin of 16.62%. Boston Scientific's return on equity of 18.61% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.36%	15.33%	9.51%
Boston Scientific	16.62%	18.61%	10.58%

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 89.1% of Boston Scientific shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by company insiders. Comparatively, 0.3% of Boston Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Boston Scientific beats HealthEquity on 9 of the 16 factors compared between the two stocks.

How does Boston Scientific compare to Merit Medical Systems?

Boston Scientific (NYSE:BSX) and Merit Medical Systems (NASDAQ:MMSI) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation and media sentiment.

In the previous week, Boston Scientific had 17 more articles in the media than Merit Medical Systems. MarketBeat recorded 21 mentions for Boston Scientific and 4 mentions for Merit Medical Systems. Boston Scientific's average media sentiment score of 1.10 beat Merit Medical Systems' score of 1.06 indicating that Boston Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	15 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

89.1% of Boston Scientific shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 0.3% of Boston Scientific shares are held by insiders. Comparatively, 0.7% of Merit Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Boston Scientific has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.56, suggesting that its stock price is 44% less volatile than the broader market.

Boston Scientific presently has a consensus price target of $61.43, indicating a potential upside of 38.92%. Merit Medical Systems has a consensus price target of $105.55, indicating a potential upside of 21.75%. Given Boston Scientific's stronger consensus rating and higher probable upside, research analysts plainly believe Boston Scientific is more favorable than Merit Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	2 Sell rating(s)	8 Hold rating(s)	20 Buy rating(s)	1 Strong Buy rating(s)	2.65
Merit Medical Systems	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.62

Boston Scientific has a net margin of 16.62% compared to Merit Medical Systems' net margin of 9.94%. Boston Scientific's return on equity of 18.61% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	16.62%	18.61%	10.58%
Merit Medical Systems	9.94%	14.12%	8.37%

Boston Scientific has higher revenue and earnings than Merit Medical Systems. Boston Scientific is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.07B	3.19	$2.90B	$2.36	18.74
Merit Medical Systems	$1.52B	3.43	$128.49M	$2.66	32.59

Summary

Boston Scientific beats Merit Medical Systems on 12 of the 17 factors compared between the two stocks.

How does Boston Scientific compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Boston Scientific (NYSE:BSX) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, risk, institutional ownership and earnings.

AMN Healthcare Services currently has a consensus price target of $39.17, suggesting a potential upside of 4.32%. Boston Scientific has a consensus price target of $61.43, suggesting a potential upside of 38.92%. Given Boston Scientific's stronger consensus rating and higher possible upside, analysts plainly believe Boston Scientific is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	1 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.33
Boston Scientific	2 Sell rating(s)	8 Hold rating(s)	20 Buy rating(s)	1 Strong Buy rating(s)	2.65

Boston Scientific has a net margin of 16.62% compared to AMN Healthcare Services' net margin of 3.10%. AMN Healthcare Services' return on equity of 23.42% beat Boston Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	3.10%	23.42%	7.19%
Boston Scientific	16.62%	18.61%	10.58%

Boston Scientific has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.53	-$95.70M	$2.75	13.65
Boston Scientific	$20.07B	3.19	$2.90B	$2.36	18.74

AMN Healthcare Services has a beta of 0.42, suggesting that its stock price is 58% less volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market.

In the previous week, AMN Healthcare Services had 2 more articles in the media than Boston Scientific. MarketBeat recorded 23 mentions for AMN Healthcare Services and 21 mentions for Boston Scientific. Boston Scientific's average media sentiment score of 1.10 beat AMN Healthcare Services' score of 0.59 indicating that Boston Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	6 Very Positive mention(s)	4 Positive mention(s)	9 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Boston Scientific	15 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 89.1% of Boston Scientific shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by insiders. Comparatively, 0.3% of Boston Scientific shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Boston Scientific beats AMN Healthcare Services on 12 of the 17 factors compared between the two stocks.

How does Boston Scientific compare to Cardinal Health?

Cardinal Health (NYSE:CAH) and Boston Scientific (NYSE:BSX) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

Boston Scientific has lower revenue, but higher earnings than Cardinal Health. Boston Scientific is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardinal Health	$254.25B	0.25	$1.71B	$7.73	35.96
Boston Scientific	$20.07B	3.19	$2.90B	$2.36	18.74

Cardinal Health currently has a consensus target price of $279.44, suggesting a potential upside of 0.53%. Boston Scientific has a consensus target price of $61.43, suggesting a potential upside of 38.92%. Given Boston Scientific's higher possible upside, analysts clearly believe Boston Scientific is more favorable than Cardinal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardinal Health	0 Sell rating(s)	3 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.89
Boston Scientific	2 Sell rating(s)	8 Hold rating(s)	20 Buy rating(s)	1 Strong Buy rating(s)	2.65

In the previous week, Cardinal Health had 11 more articles in the media than Boston Scientific. MarketBeat recorded 32 mentions for Cardinal Health and 21 mentions for Boston Scientific. Boston Scientific's average media sentiment score of 1.10 beat Cardinal Health's score of 0.70 indicating that Boston Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cardinal Health	13 Very Positive mention(s)	3 Positive mention(s)	12 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Boston Scientific	15 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

87.2% of Cardinal Health shares are owned by institutional investors. Comparatively, 89.1% of Boston Scientific shares are owned by institutional investors. 0.1% of Cardinal Health shares are owned by insiders. Comparatively, 0.3% of Boston Scientific shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cardinal Health has a beta of 0.53, indicating that its stock price is 47% less volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market.

Boston Scientific has a net margin of 16.62% compared to Cardinal Health's net margin of 0.71%. Boston Scientific's return on equity of 18.61% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardinal Health	0.71%	-102.72%	4.86%
Boston Scientific	16.62%	18.61%	10.58%

Summary

Boston Scientific beats Cardinal Health on 11 of the 16 factors compared between the two stocks.

Get Boston Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BSX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BSX vs. The Competition

Export

Metric	Boston Scientific	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$64.25B	$6.02B	$7.87B	$23.55B
Dividend Yield	N/A	1.68%	2.46%	3.74%
P/E Ratio	18.78	39.21	34.61	29.91
Price / Sales	3.20	5.57	8.89	3.42
Price / Cash	11.18	24.37	22.23	15.68
Price / Book	2.48	4.45	4.40	3.72
Net Income	$2.90B	$143.14M	$3.51B	$1.08B
7 Day Performance	3.53%	-1.37%	-1.49%	0.60%
1 Month Performance	2.30%	-2.75%	-3.90%	-0.29%
1 Year Performance	-57.78%	0.92%	0.94%	6.82%

Boston Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BSX Boston Scientific	4.4141 of 5 stars	$44.33 +0.3%	$61.43 +38.6%	-57.5%	$64.25B	$20.07B	18.78	59,000	Positive News
ALGN Align Technology	3.8348 of 5 stars	$164.90 +8.8%	$193.08 +17.1%	+17.8%	$11.81B	$4.03B	24.00	20,290	Positive News
HQY HealthEquity	3.6977 of 5 stars	$108.84 +6.7%	$113.53 +4.3%	+2.5%	$9.00B	$1.31B	39.29	2,814	Positive News
MMSI Merit Medical Systems	3.6062 of 5 stars	$90.63 +7.7%	$105.55 +16.5%	-1.6%	$5.43B	$1.52B	34.07	7,500
AMN AMN Healthcare Services	2.0572 of 5 stars	$47.70 +5.3%	$36.50 -23.5%	+126.6%	$1.85B	$2.73B	17.80	2,664

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:BSX) was last updated on 11/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Boston Scientific (BSX) Competitors

BSX vs. ALGN, HQY, MMSI, AMN, and CAH

How does Boston Scientific compare to Align Technology?

Summary

How does Boston Scientific compare to HealthEquity?

Summary

How does Boston Scientific compare to Merit Medical Systems?

Summary

How does Boston Scientific compare to AMN Healthcare Services?

Summary

How does Boston Scientific compare to Cardinal Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BSX vs. The Competition

Boston Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Boston Scientific (BSX) Competitors

BSX vs. ALGN, HQY, MMSI, AMN, and CAH

How does Boston Scientific compare to Align Technology?

Do analysts rate BSX or ALGN?

Does the media prefer BSX or ALGN?

Is BSX or ALGN more profitable?

Which has preferable earnings & valuation, BSX or ALGN?

Which has more risk and volatility, BSX or ALGN?

Do institutionals and insiders have more ownership in BSX or ALGN?

Summary

How does Boston Scientific compare to HealthEquity?

Which has more risk and volatility, HQY or BSX?

Do analysts prefer HQY or BSX?

Which has higher earnings and valuation, HQY or BSX?

Does the media refer more to HQY or BSX?

Is HQY or BSX more profitable?

Do institutionals & insiders believe in HQY or BSX?

Summary

How does Boston Scientific compare to Merit Medical Systems?

Does the media prefer BSX or MMSI?

Do insiders and institutionals believe in BSX or MMSI?

Which has more risk and volatility, BSX or MMSI?

Do analysts rate BSX or MMSI?

Is BSX or MMSI more profitable?

Which has better earnings and valuation, BSX or MMSI?

Summary

How does Boston Scientific compare to AMN Healthcare Services?

Do analysts prefer AMN or BSX?

Is AMN or BSX more profitable?

Which has stronger earnings & valuation, AMN or BSX?

Which has more risk and volatility, AMN or BSX?

Does the media favor AMN or BSX?

Do insiders & institutionals hold more shares of AMN or BSX?

Summary

How does Boston Scientific compare to Cardinal Health?

Which has higher valuation and earnings, CAH or BSX?

Do analysts recommend CAH or BSX?

Does the media refer more to CAH or BSX?

Do insiders and institutionals have more ownership in CAH or BSX?

Which has more risk and volatility, CAH or BSX?

Is CAH or BSX more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BSX vs. The Competition

Boston Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools